These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12654655)

  • 1. High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation.
    Martín-Galiano AJ; de la Campa AG
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1257-61. PubMed ID: 12654655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
    Balsalobre L; de la Campa AG
    Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.
    Pan XS; Ambler J; Mehtar S; Fisher LM
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2321-6. PubMed ID: 8891138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and genetic characterization of Streptococcus pneumoniae mutants resistant to the des-F(6) quinolone BMS-284756.
    Hartman-Neumann S; DenBleyker K; Pelosi LA; Lawrence LE; Barrett JF; Dougherty TJ
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2865-70. PubMed ID: 11557482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae.
    Enright M; Zawadski P; Pickerill P; Dowson CG
    Microb Drug Resist; 1998; 4(1):65-70. PubMed ID: 9533728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level resistance to rifampin in Streptococcus pneumoniae.
    Meier PS; Utz S; Aebi S; Mühlemann K
    Antimicrob Agents Chemother; 2003 Mar; 47(3):863-8. PubMed ID: 12604513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR-oligonucleotide ligation assay for detection of point mutations associated with quinolone resistance in Streptococcus pneumoniae.
    Bui MH; Stone GG; Nilius AM; Almer L; Flamm RK
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1456-9. PubMed ID: 12654693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae.
    Gould KA; Pan XS; Kerns RJ; Fisher LM
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2108-15. PubMed ID: 15155208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of rifampin resistance in Streptococcus pneumoniae.
    Padayachee T; Klugman KP
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2361-5. PubMed ID: 10508007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS; Fisher LM
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.
    Gootz TD; Zaniewski R; Haskell S; Schmieder B; Tankovic J; Girard D; Courvalin P; Polzer RJ
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2691-7. PubMed ID: 9124824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.
    Tankovic J; Perichon B; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2505-10. PubMed ID: 8913454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.
    Muñoz R; De La Campa AG
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2252-7. PubMed ID: 8891124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS; Yague G; Fisher LM
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic antagonism and hypermutability in Mycobacterium smegmatis.
    Karunakaran P; Davies J
    J Bacteriol; 2000 Jun; 182(12):3331-5. PubMed ID: 10852861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular bases of three characteristic phenotypes of pneumococcus: optochin-sensitivity, coumarin-sensitivity, and quinolone-resistance.
    de la Campa AG; García E; Fenoll A; Muñoz R
    Microb Drug Resist; 1997; 3(2):177-93. PubMed ID: 9185146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae.
    Varon E; Janoir C; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1999 Feb; 43(2):302-6. PubMed ID: 9925523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase.
    Alovero FL; Pan XS; Morris JE; Manzo RH; Fisher LM
    Antimicrob Agents Chemother; 2000 Feb; 44(2):320-5. PubMed ID: 10639357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
    Nagai K; Davies TA; Pankuch GA; Dewasse BE; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2740-6. PubMed ID: 10991854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.